United Patients Group

JANUARY 4, 2024

As we move forward into 2024 and beyond, the sector offers diverse paths beyond direct patient care. The growth stems from rising healthcare demand, facility expansion, and the imperative for efficient administration to maintain quality patient care. Adverse drug events (ADEs) affect approximately 7 per 100 hospitalized patients.

Research and Development 52

Research and Development Patients Data Policy 52

Cannabis Law Report

FEBRUARY 24, 2020

AusCann Group Holdings Limited told the ASX the agreement with Clifford Hallam Healthcare (CH2) to store and distribute AusCann’s pharmaceutical products was cost effective and extended AusCann’s distribution network in Australia.

Medicine 66

Medicine Pharmaceutical Compliance Compliance 66

MJ Business Attorneys

JUNE 29, 2018

Epidiolex is the first drug the FDA has approved that contains a substance derived from marijuana, and it is also the first drug approved by the FDA to be used to treat patients with Dravet syndrome. For five years Mr. Feldmann worked under the United States Drug Enforcement Division.

DEA 113

DEA CBD Pharmaceutical Research and Development 113

Cannabis Law Report

JANUARY 23, 2022

Claire gained substantial pharmaceutical experience from her work in the biotechnology industry before transferring to cannabis in 2017. a business management and regulatory consulting firm, she led numerous Licensed Producers in achieving regulatory compliance and streamlining business operations. “I Greenridez 2.0 Acquisitions Corp.

History 52

History Pharmaceutical Compliance Compliance 52

Cannabis Law Report

JUNE 3, 2022

COMPASS Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Develop, implement, and maintain written policies, procedures, and guidelines to facilitate compliance with federal, state, and local laws, regulations, and rules, and industry standards.

Legalization 59

Legalization Clinical Trials Compliance Compliance 59

Cannabis Law Report

MARCH 29, 2022

Mullette joins MAPS PBC after more than 20 years in the pharmaceutical industry. Prior to his work at Moderna, Mullette developed broad pharmaceutical expertise with Sanofi in a variety of management roles in the U.S., Mullette joins MAPS PBC after more than 20 years in the pharmaceutical industry. He holds a B.S.

Therapy 52

Therapy Pharmaceutical Clinical Trials Access 52

MMJ Recs

APRIL 1, 2024

Its non-addictive nature and minimal side effects make it an attractive alternative to conventional pharmaceuticals for many individuals seeking natural remedies. CBD Oil for Medical Conditions CBD oil has gained popularity as a versatile and accessible option for managing various medical conditions.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

Cannabis Law Report

SEPTEMBER 29, 2022

The Therapeutic Goods Administration (TGA) issued 73 infringement notices totalling $972,360 between the medicinal cannabis companies MGC Pharmaceuticals Ltd, Cannatrek Ltd and Little Green Pharma Ltd. If you suspect non-compliance in relation to therapeutic goods, you can report illegal or questionable practices online to the TGA.

Epilepsy 52

Epilepsy Conditions Media Medicine 52

NORML

JANUARY 25, 2019

At the state level this week, activists gathered in Denver in conjunction with Colorado and Denver NORML chapters to lobby their state lawmakers in favor of workplace drug testing reforms, social consumption, parental protections and expanding access to the state’s medical cannabis program. FL resident? HI resident? IA resident?

Legislation 149

Legislation Patients Oil Hemp 149

Cannabis Law Report

NOVEMBER 19, 2021

We are a diverse team that shares a deep belief in the critical need for innovation and expanded access in the treatment of mental health conditions. We are a new kind of pharmaceutical company that prioritizes public benefit over profit and is committed to sustainability, accountability, and transparency. Position Requirements.

Clinical Trials 52

Clinical Trials Research and Development Therapy Compliance 52

Cannabis Law Report

MARCH 1, 2022

COMPASS Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Develop, implement, and maintain written policies, procedures, and guidelines to facilitate compliance with federal, state, and local laws, regulations, and rules, and industry standards.

Legalization 52

Legalization Clinical Trials Compliance Compliance 52

NORML

FEBRUARY 8, 2019

Legislation is pending, Proposed Bill 350, to limit patients who use medical cannabis in compliance with state law from seeking civil actions if they are discriminated against by their employer. Click here to email your lawmakers in opposition to restricting patients’ employment rights. NORML opposes this legislation.

Legislation 172

Legislation Decriminalization Patients Access 172

Cannabis Law Report

FEBRUARY 25, 2022

The company’s EU-GMP medicinal marijuana products are currently accessible in pharmacies in Malta, ensuring that patients have safe and dependable access to high-quality marijuana. (NASDAQ: TLRY) has announced that its medical unit, Tilray Medical, has finalized the first sales of medical marijuana in Malta. Tilray Brands Inc.’s

Medicine 52

Medicine Access Patients Pharmaceutical 52

Cannabis Law Report

JANUARY 14, 2022

Is it a natural response to the fact that recreational is supposedly on the way or a the report suggests it’s hard as a patient to access so therefore people are just giving up. The current lack of market growth reflects an unfortunate reality in Germany that patient access to medical cannabis is still quite low.

Pharmaceutical 52

Pharmaceutical Extraction Oil Patients 52

Cannabis Law Report

OCTOBER 2, 2021

We are pioneering a new kind of pharmaceutical company that prioritizes public benefit and is committed to sustainability, accountability, and transparency. MAPS PBC strives to establish a supportive, equitable, and accessible work environment. Why work for MAPS Public Benefit Corporation (MAPS PBC)? Position Requirements.

Clinical Trials 52

Clinical Trials Research and Development Compliance Compliance 52

Cannabis Law Report

OCTOBER 2, 2021

COMPASS Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Develop, implement, and maintain written policies, procedures, and guidelines to facilitate compliance with federal, state, and local laws, regulations, and rules, and industry standards.

Legalization 52

Legalization Clinical Trials Compliance Compliance 52

Cannabis Law Report

SEPTEMBER 14, 2022

The cannabis-based treatment, Sativex, will now be available via NHS prescription in Scotland, to treat spasticity in MS patients. Although a limited number of people have been able to access it via the Peer Approved Clinical System (PACS) Tier 2 individual patient treatment request process.

Treatment 52

Treatment Access Patients Medicine 52

Cannabis Law Report

DECEMBER 15, 2021

“Having a supply partner that gives us access to the rapidly growing U.S. The supply of psilocybin to Mycrodose therapeutics will be in compliance with all applicable rules and regulations of the U.S. market for research purposes is absolutely key for us as we look to expand our business in 2022,” he adds.

Supply Chain 52

Supply Chain Research and Development DEA Pharmaceutical 52

Cannabis Law Report

DECEMBER 14, 2019

Prohibition Partners’ has also estimated that up to 1 per-cent of the UK population could qualify as medical cannabis patients by 2028. Initially, Farmako Limited will pursue the import of Bedrocan products from the Netherlands to the UK for end patient distribution. VANCOUVER, British Columbia, Dec.

Pharmaceutical 59

Pharmaceutical Chronic Pain Patients Epilepsy 59

Veriheal

OCTOBER 13, 2020

Elevated levels of stress can even land these individuals in more discomfort, with IBD patients risking hospitalization due to inflammation. Factors such as diet and stress are known to aggravate IBD patients, but they do not cause it. . What is IBS? What is the Difference Between IBD and IBS?

Digestion 123

Digestion Treatment Conditions Research and Development 123

Cannabis Law Report

JANUARY 28, 2022

By Maciej Konarowski, President of the Polish Medical Cannabis Patients Association and founder of the Can advocare law firm, and Conor O’Brien, Analyst at Prohibition Partners. Newly released data show that Poland is home to over 9,261 patients legally accessing medical cannabis, making it one of the largest such populations in Europe.

Legislation 52

Legislation Pharmaceutical Agriculture Cultivation 52

Cannabis Law Report

OCTOBER 10, 2021

As a think tank we develop new ideas and concepts for providing medical cannabis to patients both in Germany and Europe. Cantourage is an innovative company ensuring that patients are able to access the newest medicinal products based on cannabis. pharmacology, toxicology, chemistry).

Clinical Trials 52

Clinical Trials Therapy Medicine Policy 52

Cannabis Law Report

OCTOBER 13, 2019

We jest…… on the news of Aurora Cannabis and CTT Pharmaceutical announcing the launch of their sublingual cannabis wafers. Aurora Cannabis and CTT Pharmaceutical Announce Launch of Sublingual Cannabis Wafers. Dissolve Strips Now Available to Aurora’s Canadian Medical Patients. Here’s the press release.

Pharmaceutical 40

Pharmaceutical Patients Cannabinoids Access 40

Cannabis Law Report

FEBRUARY 15, 2019

Under strict manufacturing and pharmaceutical standards, 400 grammes of Bedrocan cannabis and 400 grammes of Bedica grown by Dutch biopharmaceutical firm, Bedrocan, was imported by IPS Specials following prescriptions issued for chronic pain at a cost of £695 per private patient. (In It has 15 wholly owned subsidiary companies.

History 56

History Legalization Chronic Pain Pharmaceutical 56

Cannabis Law Report

MARCH 25, 2020

Panaxia aims to produce within a short period of time an inventory large enough to satisfy several months of demand of all Israeli patients requiring this care. Dadi Segal , Panaxia CEO: “We are pleased to be able to extend care to our patients in Israeli who are in acute need of this kind of medicinal cannabis care.

Oil 45

Oil Pharmaceutical Epilepsy Extraction 45

SpeedWeed

AUGUST 26, 2021

Aurora Cannabis officially shipped out its first shipment of “free” dried cannabis flower to be given to a select number of patients in France. Both Aurora and Ethypharm were chosen by the National Agency for Safety Medicines and Health Products (ANSM) to deliver dried flower for use by French patients.

Chronic Pain 52

Chronic Pain Programs Patients Medicine 52

Cannabis Law Report

NOVEMBER 9, 2021

The legislation would grandfather existing state-licensed cannabis operators into the federal scheme to ensure continued patient access and incentivize participation in the legal market. -As People with certain federal cannabis convictions that were non-violent would be eligible for expungements.

Media 52

Media Legalization Marijuana Agriculture 52

Cannabis Law Report

AUGUST 12, 2021

Since 2013, medicinal cannabis has been legalized in the Czech Republic due to the amendment to the Act on pharmaceuticals, otherwise known as Act No. With medical research indicating that using the plant provides significant medical benefits, the Czech Chamber of Deputies suggested a revision to the government’s Act on pharmaceuticals.

Legalization 59

Legalization Pharmaceutical Safety Extraction 59

The Cannigma

JANUARY 19, 2022

The resulting prejudice can often discourage folks from seeking out medical cannabis as an option, and can even affect state legislature, forcing patients to overcome unnecessary and prohibitive obstacles in order to receive the treatment they need. The Cannabis Enigma is a co-production of The Cannigma and Americans for Safe Access.

Patients 83

Patients Compliance Compliance Cannabis 83

Veriheal

AUGUST 14, 2023

It’s just extremely difficult doing it with a patient count. We still have plenty of things to fight for here in Oklahoma, but at least we have access to the plant now as patients. A : Basically, learning all the compliance issues from all the organizations involved and keeping up to date on all of it.

Legalization 98

Legalization Strains Media Cannabis 98

The Cannigma

FEBRUARY 11, 2021

One of the things she does is collect and analyze data about cannabis products and how patients with different medical conditions respond to them. All of that data is packaged into software doctors can use to manage their patients’ medical marijuana treatment. “I Mara: I got in as a, a patient both for myself and for my husband.

Wellness and Beauty 125

Wellness and Beauty Data Patients Medicine 125

The Cannigma

FEBRUARY 3, 2022

of babies, to doing robotic surgery, and now, helping geriatric patients navigate cannabis medicine. It is a challenging landscape to navigate and Dr. Bone is just doing phenomenal work helping patients. I usually tell my patients, take this edible, get your paring knife out, cut it into four pieces. MB: I agree with you 100%.

Wellness and Beauty 109

Wellness and Beauty Patients Medicine Cannabis 109

Cannabis Law Report

OCTOBER 21, 2021

A new nationwide study commissioned by SICPA North America, a leading provider of regulatory compliance solutions, and conducted online by The Harris Poll among over 2,000 U.S. The Press release says. adults shows broad support for securely labeling cannabis products to verify their legitimacy and safety in the marketplace.

Safety 52

Safety Research and Development Compliance Compliance 52

Cannabis Law Report

JUNE 14, 2019

“I’m proud to establish the medical marijuana advisory committee to help expand patient access, and to advance and modernize policies to move Florida into the future of medical marijuana,” Fried said. It’s a medicine that an overwhelming majority of Floridians came together for, calling for constitutionally guaranteed access.”.

Agriculture 40

Agriculture Marijuana Research and Development Policy 40

Cannabis Law Report

JUNE 1, 2021

Steve Barbera to Vice President, Market Access. As we prepare for a potential world-class launch of Vicineum, I strongly believe that these leaders will not only bring diverse and invaluable expertise to our team but will also drive the Company to continue executing our mission to save and improve the lives of patients with cancer.”.

Research and Development 66

Research and Development Treatment Pharmaceutical Patients 66

Cannabis Law Report

JUNE 26, 2019

First and foremost, I’ll highlight the patient perspective, patients like myself who are legally registered State of Florida Medical Marijuana active ID cardholders. I am a medical patient in Florida’s Medical Marijuana Use Registry due my qualifying condition: a 2010 diagnosis of aggressive Multiple Sclerosis.

Marijuana 65

Marijuana Agriculture Research and Development Education 65

Cannabis Law Report

JANUARY 19, 2022

Psygen also provided Health Canada with consent to be identified on a public list as a licensed dealer able to provide GMP psilocybin for use in patients through Canada’s special access program (the “ SAP “). About Psygen.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Conditions 52